Clinical Lung Cancer
Издатель: Elsevier · ISSN 1525-7304 · 33 статей
- Lobectomy versus segmentectomy for centrally located, small-sized (≤ 2 cm), and radiologically solid-dominant non-small cell lung cancer: a phase III randomized controlled trial (UNLIMITED; JCOG2501)
- Tarlatamab-Associated Pain Crisis: A Multi-Institutional Case Series
- Cardiac Arrhythmias after Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
- Real-world recurrence patterns and patient outcomes after 2 years of pembrolizumab immunotherapy in advanced non-small cell lung cancer.
- Net survival and cause-specific mortality after lung cancer resection in octogenarians
- Value of 18F-FDG PET/CT to Predict PD-L1 Expression and Prognosis in Advanced Thymic Squamous Cell Carcinoma
- Clinical efficacy, safety and biomarker exploration of RET-TKIs in Chinese RET fusion-positive NSCLC: a multicenter real-world analysis
- Etiologies and Outcomes of Respiratory Failure After Immune Checkpoint Inhibitor Therapy
- Conversion Surgery After EGFR-TKI Induction for Initially Unresectable EGFR-Mutant Stage III NSCLC
- A Randomized Phase III Trial of Concurrent Chemoradiotherapy Followed by Durvalumab Consolidation, With or Without Induction Chemo-Immunotherapy, in Patients With Unresectable Locally Advanced Non–Small Cell Lung Cancer: JCOG2510 (PRIME-CRT)
- The Impact of Tumor Immune Microenvironment in EGFR-Mutant Non-Small Cell Lung Cancer on the Efficacy of Osimertinib
- Comparative Effectiveness of First-Line Tyrosine Kinase Inhibitors in ALK-Positive Metastatic Non–Small Cell Lung Cancer by Presence of Brain Metastases
- Low Baseline Absolute Neutrophil Count and Chemotherapy Safety in African American Patients with Advanced Lung Cancer: A Retrospective Cohort Study
- Assessment of Prognostic Value of CEACAM5 Expression Using Archival Tissue and Real-World Evidence of Metastatic Patients with NSCLC in United States
- Racial Disparities in Thymic Epithelial Tumors: Insights From a Multiracial Urban Cohort
- Osimertinib Plus Platinum-based Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Post-progression on First-Line Osimertinib: ORCHARD
- Durable Response After Pembrolizumab for Recurrent Tracheal Squamous Cell Carcinoma: A Case Report and Focused Literature Review
- Utility of longitudinal serum tumor markers for disease monitoring in advanced NSCLC with actionable genomic alterations
- Safety and Efficacy of Stereotactic body radiotherapy for central and ultracentral Early-Stage Lung Tumors: A Canadian Provincial Cancer Center Experience.
- Transforming the Therapeutic Landscape of HER2-Mutant NSCLC: Emerging First-Line Treatment Strategies
- SAARC Consensus Recommendations for the diagnosis and treatment of non-small-cell lung cancer (NSCLC)
- Beyond Segmentectomy: Stereotactic Body Radiotherapy as a First-Line Option Alongside Surgery for Subsolid Lung Cancer
- Outcomes and Treatment Patterns for Recurrence Following Concurrent Chemoradiation and Consolidation Durvalumab in Locally Advanced, Unresectable NSCLC: A Multi-Center Study
- Local Failure after Consecutive Versus Nonconsecutive Stereotactic Body Radiotherapy for Early-Stage NSCLC: A Systematic Review and Meta-analysis
- Modified CARG Score-Guided First-Line Treatment in Older or Vulnerable Patients With Advanced Non-Small-Cell Lung Cancer: Results of the Randomized, Phase 2 DURATION Trial (AIO-YMO/TRK-0416)
- Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern Use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
- Detection of Actionable Genomic Alterations beyond EGFR, ALK and ROS1 in Non-Small Cell Lung Carcinoma: A Real-World Evaluation of a Pathology-Led Staggered Reflex Predictive Biomarker Testing Strategy in a Resource-Limited Setting
- Real-World Outcomes and Early Progressive Disease Analysis of Nivolumab and Ipilimumab Combination Therapy in Metastatic NSCLC: LIGHT-NING Study 2.5-Year Update
- Clinical And Radiological Predictors of Pathological Response to Chemo-Immunotherapy in Surgically Resected Non-Small Cell Lung Cancer
- De Novo Lung Cancer after Lung Transplantation: Rethinking Surveillance and Early Detection